You can buy Brinsupri at the lowest price at Nextgen.ooo online pharmacy. Brensocatib is a small molecule inhibitor of dipeptidyl peptidase 1 (DPP1) used to reduce neutrophilic inflammation associated with non-cystic fibrosis bronchiectasis. Non-cystic fibrosis bronchiectasis is a chronic lung disease characterized by airway widening, mucus accumulation, and neutrophilic inflammation. Brensocatib is a first-in-class dipeptidyl peptidase 1 (DPP1) inhibitor that inhibits neutrophil serine proteases, addressing a key driver of this inflammation. It reduces exacerbations and slows lung function decline, offering a targeted approach to managing non-cystic fibrosis bronchiectasis. Brensocatib was approved by the US FDA on August 12, 2025, for use in adults and pediatric patients with non-cystic fibrosis bronchiectasis.
Brinsupri (brensocatib)
General information
Active ingredient - Brensocatib
Quantity in package - 30 pcs
Dosage - 25 mg
Storage temperature - up to 30 ° C
Country of manufacture - USA
Manufacturer - Insmed Incorporated

















